Cebix

Cebix is a biopharmaceutical company dedicated to developing treatments for diabetes complications that affect nerve, kidney, and eye function. Cebix is committed to developing a chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.